Description
This session will review a series of cases demonstrating how psychotropic polypharmacy can easily develop or present as a challenge in a variety of patient care settings (e.g. acute care, outpatient, consult-liason service). Following each case presentation, approaches to minimizing psychotropic polypharmacy/deprescribing in these settings will be discussed, as well as how to address challenges that may arise in these situations.
UAN: JA4008163-9999-21-101-H04-P
Activity Type: Knowledge Based
Date of CE Release: June 3, 2021
Date of CE Expiration: June 3, 2022
Objectives
- Discuss the prevalence of psychotropic polypharmacy in older adults
- Review the evidence on the impact of psychotropic polypharmacy on clinical outcomes
- Design potential deprescribing algorithms/interventions that can be applied in clinical practice
- Apply potential deprescribing interventions to patient cases in different healthcare settings
Acknowledgements, Accreditation, and Disclosures
Acknowledgement of Support
This webinar is supported in part by an unrestricted educational grant provided by the American Board of Psychiatry and Neurology (ABPN).
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for Geriatric Psychiatry. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for Geriatric Psychiatry. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Amedco LLC designates this activity for a maximum of1.0 ANCC contact hours.
Pharmacists
Amedco LLC designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.
Psychologists
Amedco LLC designates this activity for a maximum of 1.0 psychologist contact hours.
Social Workers
As a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social workers completing this course receive 1.0 GENERAL continuing education credits.
Disclosures
Disclosure of Relevant Financial Relationships:
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1--6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no relevant financial relationships.
- Nina Vadiei
- No relevant financial relationship exists
- Erica Garcia-Pittman
- No relevant financial relationship exists
- Christine Dozier
- No relevant financial relationship exists
- Jasmine Stephens
- No relevant financial relationship exists
- Matthew Erisman
- No relevant financial relationship exists